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PURPOSE. To evaluate foveal function in patients with inherited retinal degenerations (IRD) by
measuring visual acuity (VA) after correction of higher-order aberrations.
METHODS. Adaptive optics scanning laser ophthalmoscopy (AOSLO) was used to image cones
in 4 healthy subjects and 15 patients with IRD. The 840-nm scanning laser delivered an ‘‘E’’
optotype to measure AOSLO-mediated VA (AOSLO-VA). Cone spacing was measured at the
preferred retinal locus by two independent graders and the percentage of cones below the
average density of 47 age-similar healthy subjects was computed. Cone spacing was correlated
with best-corrected VA measured with the Early Treatment of Diabetic Retinopathy Study
protocol (ETDRS-VA), AOSLO-VA, and foveal sensitivity.
RESULTS. ETDRS-VA significantly correlated with AOSLO-VA (q ¼ 0.79, 95% confidence interval
[CI] 0.5–0.9). Cone spacing correlated with AOSLO-VA (q ¼ 0.54, 95% CI 0.02–0.7), and
negatively correlated with ETDRS letters read (q ¼ 0.64, 95% CI 0.8 to 0.2). AOSLO-VA
remained ‡20/20 until cones decreased to 40.2% (CI 31.1–45.5) below normal. Similarly,
ETDRS-VA remained ‡20/20 until cones were 42.0% (95% CI 36.5–46.1) below normal. Cone
spacing z scores negatively correlated with foveal sensitivity (q ¼ 0.79, 95% CI 0.9 to
0.4) and foveal sensitivity was ‡35 dB until cones were 43.1% (95% CI 39.3–46.6) below
average.
CONCLUSIONS. VA and foveal cone spacing were weakly correlated until cones were reduced by
40% to 43% below normal. The relationship suggests that VA is an insensitive measure of
foveal cone survival; cone spacing may be a more sensitive measure of cone loss.
Keywords: adaptive optics, visual acuity, cone photoreceptors, inherited retinal degeneration
The fovea is the most important retinal region for humanvision, yet its structure and function remain difficult to
evaluate clinically. Cone photoreceptors at the fovea are
difficult to resolve, even with adaptive optics, owing to their
tight packing1 and the limits in resolution imposed by
diffraction.2 Decline in visual performance at the fovea
(measured as visual acuity [VA] and foveal sensitivity) may
remain undetected even after extensive cone loss.3,4 Our
previous study of patients with inherited retinal degenerations
(IRDs) showed that, despite a significant correlation between
VA and foveal sensitivity with foveal cone spacing, the
relationship was both noisy and nonlinear.4 As such, standard-
ized Early Treatment of Diabetic Retinopathy Study (ETDRS)
Snellen acuity measures did not drop below normal levels
(<20/25) and foveal sensitivities remained normal (‡35 dB)
until, on average, foveal cone density was 62% and 52% below
normal, respectively.4 Although preservation of foveal function
is a beneficial adaptation for human vision, it limits the
prospects for using subjective functional tests like ETDRS to
gauge foveal health. Functional deficits may manifest only after
irreversible structural changes have already occurred. Conse-
quently, these same subjective functional tests cannot serve as
sensitive methods to monitor the effects of treatments that aim
to slow, stop, or reverse retinal degeneration.5
Structural indicators of foveal retinal health are also fraught
with problems, even those that use adaptive optics. The small
size of foveal cones makes them difficult to count, especially in
images of patients who present additional challenges to
imaging, including disease-associated cataracts, age-related
cataracts, fixation instability, and lack of experience as a
subject in advanced imaging systems. Even if foveal cones can
be counted and tracked over time, not all visible cones may be
functional. Finally, the lack of visible cones in an image does not
necessarily imply a lack of function.6,7
The need for improved tests of retinal function is widely
recognized, not only for improved measures of VA8–11 but also
perimetry,12–14 cone directionality (Stiles-Crawford effect),15,16
foveal thresholds,17 and contrast sensitivity.18–20 In our
previous report,4 we proposed several reasons why VA was
not a sensitive indicator of early cone loss. First, because foveal
cones generally oversample the retinal image, VA may be
limited by a ceiling effect imposed by the eye’s optics and
higher-level neural factors.21 Second, fixational eye movements
have been shown to improve acuity, even at the finest level.22,23
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To address the optical limitations described above, we have
developed Adaptive Optics Scanning Laser Ophthalmoscopy
(AOSLO)-mediated functional testing capabilities. Adaptive
optics removes blur in the retinal image caused by the eye’s
aberrations.24
If the lack of sensitivity to early cone loss that we reported
in the previous study is due to an optical ceiling effect, then
AOSLO-mediated acuity ought to yield a stronger correlation.
Indeed, visual performance, including VA, is improved in
young, healthy individuals using adaptive optics,21,25,26 al-
though the benefit is less evident in myopic subjects21 and is
improved with practice.27 In the current study, we used
AOSLO-mediated acuity (without eye-motion correction) to
test VA as a function of cone spacing in a cohort of patients
with IRD. We included additional structural (optical coherence
tomography [OCT] measures of cone outer segment length)
and functional (foveal sensitivity) tests. If correcting the eye’s
aberrations improves the correlation between VA and cone
spacing, then the addition of AOSLO-mediated acuity to AOSLO
imaging could enhance our ability to evaluate the fovea in
health and disease.
METHODS
Study Design
Research procedures followed the tenets of the Declaration of
Helsinki. Informed consent was obtained from all subjects. The
study protocol was approved by the institutional review boards
of the University of California, San Francisco, and the
University of California, Berkeley.
Subjects
Seven eyes of four healthy subjects with normal eye
examinations from unrelated families (one female, three male)
with an average age of 50.25 years (SD 7.85) were used as
controls; healthy subjects did not undergo genetic testing.
Twenty-two eyes from 15 patients (5 female and 10 male) with
an average age of 40.73 years (SD 11.39) with IRD from 15
unrelated families were clinically characterized (Table). Pa-
tients were excluded if they had conditions that could affect
VA, including cataract, amblyopia, and cystoid macular edema
involving the fovea. Seven participants were enrolled in a
clinical trial of an experimental treatment that was adminis-
tered to only one eye; with the fellow eye receiving a sham
treatment. Sham-treated eyes from these seven patients were
used as the study eyes for this article. For one subject (40037)
with autosomal recessive retinitis pigmentosa (ARRP), the eye
with better VA was chosen as the study eye. All eyes selected
for this study had unambiguous cones within 0.5 degrees of the
preferred retinal locus (PRL) and steady fixation. Genetic
testing was performed on patients with X-linked RP, autosomal
dominant RP, and Usher syndrome type 2 through the
eyeGENE research consortium,28 on patients with ARRP
through a research protocol29 or using a next-generation
sequencing panel on a fee-for-service basis (retinal dystrophy
panel of 181 genes; Blueprint Genetics, San Francisco, CA,
USA), and Usher syndrome type 3 on a fee-for-service basis by
the Carver nonprofit genetic testing laboratory (Iowa City, IA,
USA).30
Clinical Examination
A standard illuminated eye chart was used to measure best-
corrected VA (BCVA) according to the ETDRS protocol.31
Although VA can be specified using different scales, a common
measure is the minimal angle of resolution (MAR),31,32 and in
this study, measures of ETDRS were specified in MAR,
computed into decimal form by dividing the denominator by
the numerator of the VA fraction. We also displayed these data
as the number of letters read on the ETDRS chart to retain
consistency and comparability with the previous study.4
Perimetry Measurements
Automated perimetry (Humphrey Visual Field Analyzer HFA II
750–6116–12.6; Carl Zeiss Meditec, Inc., Dublin, CA, USA)
using a 10-2 Swedish interactive threshold algorithm was used
to measure foveal thresholds. A Goldmann III stimulus was
presented on a white background (10.03 cd/m2) with
exposure duration of 200 ms. Foveal sensitivity was displayed
in decibel scale (dB).
Cross-Sectional Thickness Measurements
Cross-sectional measures of retinal thickness at the fovea were
acquired from 20-degree horizontal and vertical spectral-
domain OCT (SD-OCT; Spectralis HRAþOCT system [Heidel-
berg Engineering, Vista, CA, USA]) B-scans through the fovea.
SD-OCT B-scans were segmented using custom software as
previously described33–37 to calculate inner and outer segment
thickness (Igor Pro 7; WaveMetrics, Lake Oswego, OR, USA) at
0.1-degree locations along the scans.38
AOSLO-Mediated VA
Before AOSLO imaging, eyes were dilated with 1.0% tropic-
amide and 2.5% phenylephrine. High-resolution images of the
cone mosaic within 0.5 degree of the PRL were obtained using
AOSLO (‘‘Region of Interest [ROI] Eccentricity,’’ Table). The
‘‘E’’ optotype was introduced onto the retina by modulating
the 840-nm scanning laser to project sharp, black letters
against a red background.2 The letter E was presented for 1
second (30 frames) during each trial oriented in one of four
directions: left, right, up, or down. The subjects reported the
orientation of the E using a keyboard. Two correct responses in
succession elicited an E of decreased size (reduced by 1.4
times), whereas one incorrect response prompted the appear-
ance of an E that increased in size (increased by 1.4 times) in
the next trial. Following seven complete reversals, the
experiment terminated. The value of the final threshold was
calculated by averaging the stimulus size of the last four
reversals. Each subject repeated the experiment six times, and
the average threshold per experiment was converted to
generate a standard MAR acuity value. This one-up/two-down
procedure usually converged to 70.7% correct performance.39
AOSLO-VA measures required an additional 15 to 20 minutes
per eye to complete these repetitions.
AOSLO Image Procurement and Cone Spacing and
Density Analysis
Montages of the macular region of the AOSLO images were
created as described.40 To identify the PRL, a 10- to 15-second
video was recorded as the subject observed a small circular
fixation target delivered through modulation of the AOSLO
scanning raster, the location of which was directly recorded in
the AOSLO video. Using custom image analysis tools created
with MATLAB (The MathWorks, Inc., Natick, MA, USA), the
mean and SD of locations of fixation points in both horizontal
and vertical directions were documented. To quantify cone
spacing measures, a density recovery profile method41 was
used as described previously.40 We chose this method to
estimate cone spacing because it allows for reliable estimates
of cone spacing in mosaics in which not every cone is visible
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and it remains a meaningful and robust metric even when the
cones are no longer close-packed into a hexagonal lattice.
Other measures of cone spacing, such as nearest neighbor
distance or row-to-row spacing, are linearly related, and so
whatever correlations are found with one metric will be
essentially the same for the others. Cone locations were
measured as eccentricity in degrees from the PRL. Cone
spacing was measured as close as possible to the PRL center by
two independent graders within a standardized 0.1-degree2 (42
3 42 pixel) box (Fig. 1); the intraclass correlation coefficient
(ICC) for the two graders was 0.49 (95% CI 0.3–0.7). Given the
small numbers of subjects, the mean absolute deviation was
compared with the mean of all cone spacing measures. The
overall mean absolute difference was 0.05 with a correspond-
ing overall mean measurement cone spacing value of 0.87. The
mean absolute difference divided by the mean measurement
value was approximately 6% of the average cone spacing value.
The measure calculated by each grader was averaged to derive
the mean cone spacing at each ROI for correlation analyses.
Due to the increase in photoreceptor density approaching the
foveal center (mean eccentricity, 0.16 degree; maximum
eccentricity, 0.24 degree), where abrupt changes in cone
FIGURE 1. AOSLO image of 43-year-old male with RP simplex (30015).
The blue crosses indicate the fixation locus, and its centroid was used
to determine the PRL for fixation. The green box outlines the ROI
selected for cone spacing analysis. Inset: Magnified view of the ROI
with red dots indicating the selected cone locations.
FIGURE 2. Visual acuity measured after correction with AOSLO is
significantly correlated with visual acuity measured using ETDRS
charts. Correlation of ETDRS MAR acuity and AOSLO acuity, normal
subjects: r¼0.33, 95% CI:1.0 to 0.3; IRD patients: r¼ 0.79, 95% CI:
0.5 to 0.9. Normal subjects: blue circles; IRD patients: red Xs.
FIGURE 3. Visual acuity measured after correction with AOSLO is
significantly correlated with visual acuity measured with numbers of
letters read using ETDRS charts. Correlation of acuity measured as
letters read on the ETDRS chart and AOSLO acuity measured as MAR,
normal subjects: r¼0.02, 95% CI:0.9 to 1.0; IRD patients: r¼0.84,
95% CI: 0.9 to 0.6. Normal subjects: blue circles; IRD patients: red
Xs.
FIGURE 4. Visual acuity measured after correction with AOSLO is
significantly correlated with cone loss measured as increased cone
spacing z score. (A) Correlation of cone spacing z scores and AOSLO
acuity, normal subjects: r¼ 0.37, 95% CI:0.8 to 1.0; IRD patients: r¼
0.54, 95% CI: 0.02 to 0.7. (B) Correlation of % cones below average and
AOSLO acuity; red line: threshold percent cone loss where vision drops
below normal MAR >1.00 (20/20 VA): 40.2%, red shading: 95% CI:
31.1 to 45.5; blue line: threshold percent cone loss where vision drops
below normal MAR >1.25 (20/25 VA): 48.9%, blue shading: 95% CI:
44.5 to 58.6. Normal subjects: blue circles; IRD patients: red Xs.
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spacing would impact the results, cone spacing measures were
converted to z scores (SDs from normal spacing), which are
expected to be more uniform across the foveal region. Z scores
were based on mean cone spacing at the measured eccentricity
calculated from a larger normal data set42 composed of 10
controls (4 male, 6 female) between ages 25 and 58 (average
45.2 years, SD 10.3 years); normal z scores were between 2
and 2.
Data Analysis and Statistics
All cone spacing measurements were correlated with ETDRS-
VA, AOSLO-mediated VA, and foveal sensitivity. Correlations
between parameters were assessed using the Spearman rank
correlation coefficient q, and a bootstrap analysis clustered by
patient to account for the fact that one eye was used in some
subjects and both eyes were used in others was used to derive
the 95% confidence interval (CI) values. Statistical significance
was determined using the 95% CIs. The percentage of cones
below average was computed to indicate the difference in
cone density from the average of 47 healthy subjects, as
described in our previous study.4 The percentage of cone loss
needed to reach performance scores below specified thresh-
olds, for example, below a MAR of 1.0 (20/20 VA) are indicated
by the red and blue lines on Figures 4B, 5B, and 6B, and were
computed from a quadratic curve fitting that was then
bootstrapped to obtain the 95% bias-corrected/accelerated CIs.
FIGURE 5. Visual acuity measured using standardized eye charts
according to the ETDRS protocol is significantly correlated with cone
loss measured as increased cone spacing z score. (A) Correlation of
cone spacing z scores and ETDRS acuity, normal subjects: r¼0.16, 95%
CI: 1.0 to 0.8; IRD patients: r ¼ 0.64, 95% CI: 0.8 to 0.2. (B)
Correlation of % cones below average and ETDRS acuity, red line:
threshold percent cone loss where vision drops below normal <85
letters (20/20 VA): 42.0%, red shading: 95% CI: 36.5 to 46.1; blue line:
threshold percent cone loss where vision drops below normal <80
Letters (20/25 VA): 49.5%, blue shading: 95% CI: 46.2 to 59.7. BCVA,
best corrected visual acuity; normal subjects: blue circles; IRD patients:
red Xs.
FIGURE 6. Foveal sensitivity is significantly correlated with cone loss
measured as increased cone spacing z score. (A) Correlation of cone
spacing z scores and foveal sensitivity, normal subjects: r¼0.19, 95%
CI: 0.8 to 1.0; IRD patients r ¼ 0.79, 95% CI: 0.9 to 0.4. (B)
Correlation of % cones below average and foveal sensitivity; red line:
threshold percent cone where vision drops below normal foveal
sensitivity (<35 dB): 43.1%, red shading: 95% CI: 39.3 to 46.6. dB,
decibels; normal subjects: blue circles; IRD patients: red Xs.
FIGURE 7. OS thickness is significantly correlated with cone loss
measured as increased cone spacing z score. Correlation of cone
spacing z scores and OS thickness, normal subjects: r¼0.54, 95% CI:
0.9 to 1.0; IRD patients: r ¼ 0.61, 95% CI: 0.8 to 0.2. Normal
subjects: blue circles; IRD patients: red Xs.
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RESULTS
ETDRS-VA was not significantly correlated with AOSLO-VA in
healthy subjects (q ¼0.33, 95% CI 1.0 to 0.3), but it was
significantly correlated in IRD patients (q ¼ 0.79, 95% CI 0.5–
0.9) (Fig. 2). Similarly, ETDRS Letters Read correlated
negatively with AOSLO-VA (Fig. 3); the correlation was not
significant in healthy subjects (q¼0.02, 95% CI0.9 to 1.0),
but was significant in IRD patients (q¼0.84, 95% CI0.9 to
0.6).
The cone spacing z scores and AOSLO-VA relationship was
significant in IRD patients (q¼ 0.54, 95% CI 0.02–0.7), but not
in healthy subjects (q¼0.37, 95% CI0.8 to 1.0). Cone spacing
z scores were also significantly correlated with ETDRS Letters
Read in IRD patients (q¼0.64, 95% CI:0.8 to0.2), but not
in healthy subjects (q ¼ 0.16, 95% CI 1.0 to 0.8). The
similarity in correlation of AOSLO-VA and ETDRS with z scores
suggests that correcting the optical aberrations in this cohort
of subjects did not give rise to improved structure/function
relationships.
Figure 4B plots AOSLO-VA versus percentage of cones
below average. The analysis shows that cone density decreased
to 40.2% below normal (95% CI 31.1–45.5) before AOSLO-VA
dropped below 20/20, and decreased to 48.9% fewer cones
than normal (95% CI 44.5–58.6) before AOSLO-VA dropped
below 20/25. Figure 5B plots are similar to 4B, but with ETDRS-
VA rather than AOSLO-VA. The cone density thresholds
associated with acuity below 20/20 and 20/25 were 42.0%
(95% CI 36.5–46.1) and 49.5% fewer than normal (95% CI
46.2–59.7), respectively.
Cone spacing z scores were significantly correlated with
foveal sensitivity in IRD patients (q ¼0.79, 95% CI 0.9 to
0.4), but not in healthy subjects (q ¼0.19, 95% CI 0.8 to
1.0). A percentage of cones below average of 43.1% (95% CI
39.3–46.6) or more would be needed to detect a drop in foveal
sensitivity below 35 dB (Fig. 6B).
Finally, when cone spacing z scores were analyzed with
cross-sectional measures of outer segment (OS) thickness, a
significant correlation was seen in IRD patients alone (q ¼
0.61, 95% CI 0.8 to 0.2), but not in healthy subjects (q ¼
0.54, 95% CI 0.9 to 1.0) (Fig. 7).
DISCUSSION
The present study revealed significant correlations between
measures of cone structure with measures of visual function at
or near the fovea. As cone spacing increased, there was a
significant decline in VA. Additionally, ETDRS-VA and AOSLO-
VA were similarly correlated with cone spacing z scores
measured near the foveal center. In both cases, the relationship
was noisy and nonlinear. Furthermore, a similar reduction in
cone density of approximately 40% below normal was required
before clinically measurable changes in either measure of
acuity were observed. Despite correcting for optical imperfec-
tions, AOSLO-VA did not result in significant improvement in
this structure/function relationship.
One notable finding was that for all healthy subjects, and
just under half of the IRD subjects, AOSLO-VA was worse than
ETDRS-VA. We offer four possible explanations for this.
First, ETDRS-VA and AOSLO-VA not only used different
methods (letters read on an acuity chart versus a four-
alternative-forced-choice tumbling E staircase procedure) but
also converged to different thresholds (82%31 vs. 70.7%39
correct). This is an unlikely explanation, because, if anything,
the lower threshold for the AOSLO-VA ought to have yielded
slightly better performance, but it did not.
Second, AOSLO-VA was administered using 840-nm light
with more than 20 times lower luminance (approximately 4
cd/m2) than the standard light box used to measure ETDRS-VA
(85 cd/m2). AOSLO-VA measures that were better than clinical
measures of VA were achieved using nearly identical measure-
ment conditions and a similar system in earlier reports.2 The
subjects in the earlier reports, however, were healthy, younger,
emmetropic, and had extensive experience using the AOSLO
system.
Third, a possible interpretation for the lack of improve-
ments in VA with aberration correction could be that the
receptive fields in our subjects (both healthy and IRD
subjects) comprise more than single cones. Eliminating the
aberrations would confer little benefit if this were the case,
which is what we found, and a random loss of cones within
larger receptive field would only have minimal effects on the
sampling resolution until many cones were lost, which is
also what we found. However, we have every reason to
believe that there are at least two midget ganglion cells per
foveal cone in our healthy subjects and that cone spacing
imposes the retinal limit on foveal VA. Measurement of the
limits of human spatial vision at the fovea in young healthy
eyes confirms this.2 It is very unlikely that this ratio would
be any different in the slightly older healthy subjects we
used for this study (average age of 50 years) and the
comparable acuity of the less-advanced IRD patients suggests
that this is true for them as well.
The most likely explanation arises from the facts that
subjects in this study were older, perhaps with subclinical lens
opacities, were unfamiliar with the AOSLO-VA task, were not
emmetropic (see Table), and had little or no experience being
imaged in an AOSLO. Collectively, these facts probably explain
why AOSLO-VA measures were slightly worse than ETDRS-VA.
This final explanation is important, because, until AOSLO-
mediated functional tests become more widely available,
robust, and efficient, subjects will often have limited experi-
ence with the test.
IRD subjects seemed to benefit more from adaptive optics
(AO) correction than healthy subjects, perhaps because the
IRD subjects’ aberrations were, on average, greater. Greater
aberrations in RP patients have been reported,43 but the
aberration of the eyes in our study was not recorded or
analyzed before AO correction.
Cone Spacing Compared With ETDRS and AOSLO
Acuities
In patients with IRD, both ETDRS and AOSLO-mediated
acuities were correlated with cone spacing z scores. The
significant correlations demonstrated that greater cone spac-
ing, indicating cone loss, corresponded to worse acuity
performance. Healthy subjects, however, did not demonstrate
a statistically significant correlation between acuity and cone
spacing. It is clear that factors outside of cone spacing and
optics (see earlier discussion) govern acuity performance in
the normal healthy eyes that were part of this study. There are
no obvious advantages of AOSLO-mediated acuity over
conventional measures for assessing foveal structure.
We consistently found that VA did not decrease until cone
densities were approximately 40% lower than the average for
normal eyes. The thresholds for ETDRS acuity were similar to a
previous study, and the present study demonstrated a similar
threshold for AOSLO-mediated VA.4 Despite differences in the
actual reported thresholds, the 95% CIs between studies
overlap (compare Figs. 4B, 5B in the present paper with Fig.
4 from Ratnam et al.4).
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Cone Spacing Compared With Foveal Sensitivity
As with acuity, there was a significant relationship between
foveal sensitivity and cone spacing z scores, but the data
were noisy and nonlinear, and significant declines in foveal
sensitivity were not observed reliably until cones were well
below the normal average. The cone density threshold to
detect foveal sensitivities below 35 dB was similar between
the current and our previous report.4 Although the
thresholds were different (43% vs. 52%4), the 95% CIs
overlapped. However, the range of percentage cone loss
associated with reduced VA and foveal sensitivity was
narrower in the present study, refining the threshold to
near 40% to 50% cone loss for all abnormal measures of
foveal function. As reported in previous studies based on
computer modeling,3 visual (grating) acuity is not directly
associated with the mean density or spacing of photorecep-
tors at the fovea.
Cone Spacing Compared With OS Thickness
For IRD, cone spacing z scores correlated negatively with OS
thickness. As cones degenerate, the OS becomes thinner,
due to decreased length of OS, which likely precedes cone
loss with increased cone spacing during degeneration.44,45
However, no correlation was observed in healthy subjects,
due to the absence of photoreceptor degeneration.
CONCLUSIONS
In conclusion, even after correcting high-order aberrations,
the relationship between VA and foveal cone spacing was
weak until cone densities were 40% to 50% lower than the
normal average. The nonlinear relationship and variability
suggest that VA, whether measured by conventional methods
or with optical correction through the AOSLO, remains an
ineffective way to gauge early changes in foveal cone
spacing or density, and that cone spacing may be a more
sensitive measure of cone loss in early stages of degenera-
tion. On a positive note, the fact that AOSLO imaging can
detect structural changes in the cones well in advance of the
acuity loss means that there is a therapeutic window within
which one can treat and monitor effectiveness in advance of
any visual impact for the patient.
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